Alzheimer's drug lecanemab gains rapid approval amid safety concerns |  CNN

Alzheimer’s drug lecanemab gains rapid approval amid safety concerns | CNN

CNN – The U.S. Food and Drug Administration granted accelerated approval Friday for the Alzheimer’s disease drug licanimab, one of the first experimental dementia drugs that appears to slow the progression of cognitive decline. “Alzheimer’s disease immeasurably disrupts the lives of those who suffer from it and has devastating effects on their loved ones,” said …

Alzheimer’s drug lecanemab gains rapid approval amid safety concerns | CNN Read More »